PQ 1831
1831. Deputy Peadar Tóibín asked the Minister for Health further to Parliamentary Question No. 1514 of 14 June 2022, the status of the application received by the HSE corporate pharmaceutical unit for pricing and reimbursement of semaglutide 2.4mg (details supplied) on 6 May 2022 from a company; and if he will make a statement on the matter. [43245/22]
Introduced
8 September 2022
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
8 September 2022
Summary
1831. Deputy Peadar Tóibín asked the Minister for Health further to Parliamentary Question No. 1514 of 14 June 2022, the status of the application received by the HSE corporate pharmaceutical unit for pricing and reimbursement of semaglutide 2.4mg (details supplied) on 6 May 2022 from a company; and if he will make a statement on the matter. [43245/22]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Health Service Executive
Health Service Executive
xml · EN · 8 September 2022
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2022-09-08/1831/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2022-09-08/pq_1831